CA Stock MarketDetailed Quotes

WLLW Willow Biosciences Inc

Watchlist

0.120
+0.005+4.35%

15min DelayMarket Closed Jul 5 16:00 ET

15.27MMarket Cap-1500P/E (TTM)

Willow Biosciences Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-84.36%1.64M

-78.94%3.17M

-80.03%3.68M

-70.61%6.49M

-60.21%10.49M

-50.11%15.03M

-48.43%18.43M

-45.81%22.07M

-Cash and cash equivalents

-84.52%1.62M

-71.43%3.15M

-80.03%3.68M

-70.70%6.47M

-60.28%10.47M

-63.45%11.01M

-48.43%18.43M

-45.81%22.07M

-Accounts receivable

-67.26%148K

-41.13%166K

406.72%603K

-87.50%20K

375.79%452K

587.80%282K

-50.62%119K

-51.81%160K

Total current assets

-79.39%2.37M

-74.30%4.17M

-71.03%5.69M

-66.77%7.84M

-57.77%11.51M

-48.10%16.23M

-47.45%19.64M

-44.46%23.59M

Non current assets

-Accumulated depreciation

----

5.46%-10.09M

-17.35%-9.65M

-14.95%-9.1M

10.73%-6.33M

---10.67M

-45.28%-8.23M

-58.93%-7.91M

-Long term equity investment

7,461.11%1.36M

4,353.13%1.43M

2,197.73%1.01M

2,012.28%1.2M

--18K

-80.12%32K

-46.34%44K

-55.47%57K

-Other intangible assets

--44K

----

Regulatory assets

-67.26%148K

-41.13%166K

406.72%603K

-87.50%20K

375.79%452K

216.85%282K

-50.62%119K

-51.81%160K

Liabilities

Current liabilities

Current debt and capital lease obligation

37.22%671K

15.66%731K

61.63%653K

45.09%798K

-22.13%489K

-1.40%632K

-4.94%404K

4.17%550K

-Current debt

----

--82K

----

-Current capital lease obligation

37.22%671K

2.69%649K

61.63%653K

45.09%798K

-22.13%489K

-1.40%632K

-4.94%404K

4.17%550K

-accounts payable

----

--538K

----

-Total tax payable

6,380.95%1.36M

2,490.91%1.43M

953.13%1.01M

361.45%1.21M

-98.89%21K

-98.60%55K

-98.13%96K

-98.24%262K

-Due to related parties current

----

--301K

----

-Other payable

----

-32.63%64K

----

400.00%100K

375.00%95K

Current deferred liabilities

43.29%523K

--446K

--272K

--442K

--365K

--0

Current liabilities

-2.68%1.67M

5.41%1.81M

79.27%1.76M

19.37%1.74M

38.31%1.72M

22.09%1.72M

-36.92%984K

-1.15%1.46M

Non current liabilities

-Long term debt

3,655.56%676K

2,496.88%831K

2,197.73%1.01M

2,012.28%1.2M

--18K

-80.12%32K

-46.34%44K

-55.47%57K

Non current accrued expenses

7.06%2.14M

27.05%2.44M

24.80%2.78M

31.32%3.3M

-33.26%2M

-47.42%1.92M

-38.94%2.23M

-36.14%2.51M

Derivative product liabilities

----

--0

-97.56%5K

-99.84%3K

-99.39%23K

-98.97%52K

-98.61%205K

Long term provisions

--685K

--594K

----

Total non current liabilities

74.54%3.03M

82.47%3.24M

156.94%2.78M

71.54%2.95M

-44.43%1.74M

-66.74%1.77M

-83.87%1.08M

-89.52%1.72M

Shareholders'equity

Share capital

0.29%118.45M

0.09%118.18M

0.04%118.12M

0.06%118.1M

0.04%118.07M

-common stock

0.29%118.45M

0.09%118.18M

0.04%118.12M

0.06%118.1M

0.04%118.07M

Additional paid-in capital

0.20%7.47M

-0.12%7.31M

2.20%7.28M

11.22%7.52M

16.61%7.46M

24.01%7.32M

32.45%7.12M

38.37%6.76M

Retained earnings

----

--301K

----

Gains losses not affecting retained earnings

-2.46%-375K

-13.15%-413K

-6.74%-380K

10.20%-352K

9.85%-366K

10.98%-365K

14.01%-356K

1.01%-392K

Total equity

-66.12%4.57M

-63.23%6.67M

-61.14%8.54M

-57.23%11.2M

-55.48%13.5M

-48.17%18.15M

-46.47%21.97M

-43.58%26.19M

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-84.36%1.64M	-78.94%3.17M	-78.94%3.17M	-80.03%3.68M	-70.61%6.49M	-60.21%10.49M	-50.11%15.03M	-50.11%15.03M	-48.43%18.43M	-45.81%22.07M
-Cash and cash equivalents	-84.52%1.62M	-71.43%3.15M	-71.43%3.15M	-80.03%3.68M	-70.70%6.47M	-60.28%10.47M	-63.45%11.01M	-63.45%11.01M	-48.43%18.43M	-45.81%22.07M
-Accounts receivable	-67.26%148K	-41.13%166K	-41.13%166K	406.72%603K	-87.50%20K	375.79%452K	587.80%282K	587.80%282K	-50.62%119K	-51.81%160K
Total current assets	-79.39%2.37M	-74.30%4.17M	-74.30%4.17M	-71.03%5.69M	-66.77%7.84M	-57.77%11.51M	-48.10%16.23M	-48.10%16.23M	-47.45%19.64M	-44.46%23.59M
Non current assets
-Accumulated depreciation	----	5.46%-10.09M	5.46%-10.09M	-17.35%-9.65M	-14.95%-9.1M	10.73%-6.33M	---10.67M	---10.67M	-45.28%-8.23M	-58.93%-7.91M
-Long term equity investment	7,461.11%1.36M	4,353.13%1.43M	4,353.13%1.43M	2,197.73%1.01M	2,012.28%1.2M	--18K	-80.12%32K	-80.12%32K	-46.34%44K	-55.47%57K
-Other intangible assets	--44K	--44K	--44K	----	----	----	----	----	----	----
Regulatory assets	-67.26%148K	-41.13%166K	-41.13%166K	406.72%603K	-87.50%20K	375.79%452K	216.85%282K	216.85%282K	-50.62%119K	-51.81%160K
Liabilities
Current liabilities
Current debt and capital lease obligation	37.22%671K	15.66%731K	15.66%731K	61.63%653K	45.09%798K	-22.13%489K	-1.40%632K	-1.40%632K	-4.94%404K	4.17%550K
-Current debt	----	--82K	--82K	----	----	----	----	----	----	----
-Current capital lease obligation	37.22%671K	2.69%649K	2.69%649K	61.63%653K	45.09%798K	-22.13%489K	-1.40%632K	-1.40%632K	-4.94%404K	4.17%550K
-accounts payable	----	----	----	--538K	----	----	----	----	----	----
-Total tax payable	6,380.95%1.36M	2,490.91%1.43M	2,490.91%1.43M	953.13%1.01M	361.45%1.21M	-98.89%21K	-98.60%55K	-98.60%55K	-98.13%96K	-98.24%262K
-Due to related parties current	----	----	----	--301K	----	----	----	----	----	----
-Other payable	----	----	----	----	-32.63%64K	----	----	----	400.00%100K	375.00%95K
Current deferred liabilities	43.29%523K	--446K	--446K	--272K	--442K	--365K	--0	--0	--0	--0
Current liabilities	-2.68%1.67M	5.41%1.81M	5.41%1.81M	79.27%1.76M	19.37%1.74M	38.31%1.72M	22.09%1.72M	22.09%1.72M	-36.92%984K	-1.15%1.46M
Non current liabilities
-Long term debt	3,655.56%676K	2,496.88%831K	2,496.88%831K	2,197.73%1.01M	2,012.28%1.2M	--18K	-80.12%32K	-80.12%32K	-46.34%44K	-55.47%57K
Non current accrued expenses	7.06%2.14M	27.05%2.44M	27.05%2.44M	24.80%2.78M	31.32%3.3M	-33.26%2M	-47.42%1.92M	-47.42%1.92M	-38.94%2.23M	-36.14%2.51M
Derivative product liabilities	----	--0	--0	--0	-97.56%5K	-99.84%3K	-99.39%23K	-99.39%23K	-98.97%52K	-98.61%205K
Long term provisions	--685K	--594K	--594K	----	----	----	----	----	----	----
Total non current liabilities	74.54%3.03M	82.47%3.24M	82.47%3.24M	156.94%2.78M	71.54%2.95M	-44.43%1.74M	-66.74%1.77M	-66.74%1.77M	-83.87%1.08M	-89.52%1.72M
Shareholders'equity
Share capital	0.29%118.45M	0.09%118.18M	0.09%118.18M	0.04%118.12M	0.04%118.12M	0.06%118.1M	0.04%118.07M	0.04%118.07M	0.04%118.07M	0.04%118.07M
-common stock	0.29%118.45M	0.09%118.18M	0.09%118.18M	0.04%118.12M	0.04%118.12M	0.06%118.1M	0.04%118.07M	0.04%118.07M	0.04%118.07M	0.04%118.07M
Additional paid-in capital	0.20%7.47M	-0.12%7.31M	-0.12%7.31M	2.20%7.28M	11.22%7.52M	16.61%7.46M	24.01%7.32M	24.01%7.32M	32.45%7.12M	38.37%6.76M
Retained earnings	----	----	----	--301K	----	----	----	----	----	----
Gains losses not affecting retained earnings	-2.46%-375K	-13.15%-413K	-13.15%-413K	-6.74%-380K	10.20%-352K	9.85%-366K	10.98%-365K	10.98%-365K	14.01%-356K	1.01%-392K
Total equity	-66.12%4.57M	-63.23%6.67M	-63.23%6.67M	-61.14%8.54M	-57.23%11.2M	-55.48%13.5M	-48.17%18.15M	-48.17%18.15M	-46.47%21.97M	-43.58%26.19M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

WLLW Willow Biosciences Inc

Willow Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow